Related Experiment Video
Updated: Oct 6, 2025

Lighting Up the Pathways to Caspase Activation Using Bimolecular Fluorescence Complementation
Published on: March 5, 2018
Cellular autophagy, an unbidden effect of caspase inhibition by zVAD-fmk
Dharaniya Sakthivel1,2,3, Beatriz E Bolívar2,3, Lisa Bouchier-Hayes2,3,4
1Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA.
Abstract:
zVAD-fmk is a widely used pan-caspase inhibitor that blocks apoptosis but has undesirable side effects, including autophagy. In this issue, Needs et al. propose that zVAD-fmk induces autophagy by inhibiting the N-glycanase NGLY1 rather than caspases. NGLY1 is essential for the ERAD response and patients with inactivating mutations in NGLY1 present with neurodevelopmental defects and organ dysfunction. The ability of NGLY1 to inhibit basal levels of autophagy may contribute to this pathology. This study demonstrates possible crosstalk between protein turnover and autophagy while also underscoring the importance of specificity when using chemical tools to interrogate these pathways. Comment on https://doi.org/10.1111/febs.16345.
Insights
The pan-caspase inhibitor zVAD-fmk induces autophagy by inhibiting N-glycanase NGLY1, not caspases. This finding reveals a link between protein turnover and autophagy, crucial for understanding NGLY1-related disorders.
Area of Science:
- Biochemistry
- Cell Biology
- Molecular Biology
Background:
- The pan-caspase inhibitor zVAD-fmk is commonly used to block apoptosis.
- zVAD-fmk has known side effects, including the induction of autophagy.
- The precise mechanism by which zVAD-fmk induces autophagy remains unclear.
Purpose of the Study:
- To investigate the mechanism by which zVAD-fmk induces autophagy.
- To determine if N-glycanase NGLY1 is involved in zVAD-fmk-induced autophagy.
- To explore the relationship between NGLY1, protein turnover, and autophagy.
Main Methods:
- Utilizing chemical inhibitors and genetic approaches to study cellular pathways.
- Assessing the impact of zVAD-fmk on NGLY1 activity.
- Analyzing the effects of NGLY1 inhibition on autophagy levels.
Main Results:
- zVAD-fmk induces autophagy by inhibiting N-glycanase NGLY1.
- NGLY1 inhibition, rather than caspase inhibition, is responsible for zVAD-fmk's autophagic side effect.
- NGLY1 plays a role in regulating basal autophagy levels.
Conclusions:
- The study identifies NGLY1 as a novel target mediating zVAD-fmk-induced autophagy.
- This finding highlights potential crosstalk between protein turnover pathways and autophagy.
- Emphasizes the importance of chemical tool specificity in biological research, particularly concerning NGLY1 and neurodevelopmental disorders.
Related Concept Videos
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Caspases
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
The Intrinsic Apoptotic Pathway
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized...
The Extrinsic Apoptotic Pathway

